Panelists discuss the expanding clinical development of cretostimogene across multiple NMIBC populations and treatment strategies, highlighting ongoing trials exploring its use as monotherapy and in ...

Panelists discuss the final BOND-3 trial results, highlighting intravesical cretostimogene’s strong efficacy, durable responses, and excellent safety profile in BCG-unresponsive carcinoma in situ (CIS ...

In a groundbreaking cross-border collaboration, Cleveland Clinic urologists recently completed the world's first remotely performed robot-assisted high-intensity focused ultrasound (HIFU) focal ...

Amy E. Krambeck, MD, discusses how to define success and how to determine the optimal timing for adding on a new partner. On the former, Krambeck noted that it’s important to take into account number ...

The test utilizes chromosomal instability signatures to predict resistance to taxane-based chemotherapy in metastatic prostate cancer.

Key Takeaways Lutetium (177Lu) rhPSMA-10.1 showed higher radiation doses in tumors than in normal organs, indicating a favorable therapeutic index in mCRPC patients. The phase 1 trial demonstrated a ...

Key Takeaways Detalimogene voraplasmid received RMAT designation, expediting its development for high-risk BCG-unresponsive NMIBC with CIS. The investigational therapy is a non-viral gene-based ...

“The takeaway is that on a population level, on a health care system perspective, it's more cost-effective and safer to do transperineal prostate biopsy,” says Mitchell M. Huang, MD.

Alicia K. Morgans, MD, MPH, highlights quality of life data from the phase 3 ARANOTE trial. The phase 3 ARANOTE trial (NCT04736199) showed that the addition of darolutamide (Nubeqa) to androgen ...

David Stanley, MD, FACS, discusses current trends and unmet needs in the treatment of patients with kidney stones.

Howard B. Goldman, MD, FACS, discusses innovations such as tibial nerve stimulation devices, pudendal nerve targeting, and alternative stimulation frequencies.

Panelists discuss how the new PET technology could identify lymph node involvement not visible on conventional imaging, providing actionable information for surgical planning or indicating the need ...